Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of ZOC2017217 ophthalmic suspension in senile cataract
CTR20251148Phase 2Active
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZOC2017217 in senile cataract (ARC), sponsored by Zhongshan Ophthalmic Center. Started Mar 2025; status: active.
02
Drugs
ZOC2017217
03
Conditions
senile cataract (ARC)
Beyond the preview
Go deeper on CTR20251148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251148.